# Submitting Marketing Applications According to the ICH/CTD Format: General Considerations - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/submitting-marketing-applications-according-to-the-ichctd-format-general-considerations/aab838ec-4495-4d46-a53a-ccd911049363

> FDA guidance document: Submitting Marketing Applications According to the ICH/CTD Format: General Considerations. Issue date: September 01, 2001. Get complete insights and analysis.

---

## Details

- Title: Submitting Marketing Applications According to the ICH/CTD Format: General Considerations
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2001-09-01
- Last Changed: 2019-04-05

## Related Documents

- [Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action](https://www.globalkeysolutions.net/guidances/guidance-document/bioavailability-and-bioequivalence-studies-for-nasal-aerosols-and-nasal-sprays-for-local-action/c75f03a9-fe74-43cb-90de-ab8a4cbbd770)
- [Submitting Debarment Certification Statements](https://www.globalkeysolutions.net/guidances/guidance-document/submitting-debarment-certification-statements/02f51441-128a-4fc9-a874-1feac482d4d7)
- [How to Comply with the Pediatric Research Equity Act](https://www.globalkeysolutions.net/guidances/guidance-document/how-to-comply-with-the-pediatric-research-equity-act/beb13ca3-608c-4121-93d4-787450c752ba)